Management of Junctional Bradycardia

Immediate Assessment and Stabilization

The American Heart Association recommends determining if the bradycardia is causing symptoms, and checking for signs of hemodynamic instability, such as acute altered mental status, ischemic chest pain, acute heart failure, hypotension with systolic BP <90 mmHg, or other signs of shock, in patients with junctional bradycardia 1, 2
Maintaining a patent airway, assisting breathing as necessary, providing supplementary oxygen if hypoxemic, establishing IV access, and attaching a cardiac monitor are crucial steps in the initial management of junctional bradycardia 2
Obtaining a 12-lead ECG to better define the rhythm and monitoring blood pressure and pulse oximetry continuously are also important in the assessment and stabilization of patients with junctional bradycardia 2

The American College of Cardiology recommends atropine 0.5-1 mg IV as the first-line treatment for symptomatic hemodynamically unstable patients with junctional bradycardia, with a Class IIa recommendation 1, 2
Repeating atropine every 3-5 minutes if bradycardia persists and symptoms continue, with a maximum total dose, is a recommended approach for patients with junctional bradycardia 2
Escalating to chronotropic infusions, such as dopamine or epinephrine, or transcutaneous pacing, is recommended if atropine fails or is contraindicated, with a Class IIa recommendation 1, 2
Dopamine infusion at 5-20 mcg/kg/min IV, particularly if hypotension is present, is a recommended approach for patients with junctional bradycardia who do not respond to atropine 2
Epinephrine infusion at 2-10 mcg/min IV is also a recommended approach for patients with junctional bradycardia who do not respond to atropine 1, 2

The distinction between junctional bradycardia and junctional tachycardia is critical, as management differs significantly, with beta blockers being first-line therapy for junctional tachycardia, not atropine 4, 5
Focal junctional tachycardia, which is rare in adults, may lead to heart failure if incessant, and requires beta blockers as first-line therapy, with intravenous propranolol or other beta blockers being reasonable for acute treatment, with a Class IIa recommendation 4, 5